Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
135.42
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novo Nordisk A/S ADR
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
51
52
Next >
Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs
October 27, 2023
Ozempic, Novo Nordisk’s (NYSE: NVO) diabetes drug, is now popular for weight loss. The rise of the drug could become a major headwind for other companies that provide weight-loss services such...
Via
Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
October 27, 2023
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Via
Investor's Business Daily
3 Monster Buy-and-Hold Growth Stocks to Buy Right Now for $1K
October 27, 2023
These are three growth stocks you will want to buy and never sell if you have $1,000 available to invest today.
Via
InvestorPlace
Weight Loss Drugs Like Wegovy Would Not Impact Business - Healthcare Companies Tell Investors
October 27, 2023
Novo Nordisk A/S (NYSE: NVO) investors and analysts eagerly await the company's third-quarter results, hoping for clarity on when supply limitations for its weight-loss drug, Wegovy, in the U.S.
Via
Benzinga
Looking At Novo Nordisk's Recent Unusual Options Activity
October 26, 2023
Via
Benzinga
(NVO) - Analyzing Novo Nordisk's Short Interest
October 24, 2023
Via
Benzinga
1 Green Flag and 1 Red Flag for Novo Nordisk
October 24, 2023
Even this high-flying company has its detractors.
Via
The Motley Fool
$1000 Invested In Novo Nordisk 5 Years Ago Would Be Worth This Much Today
October 20, 2023
Via
Benzinga
Q3 Earnings Season Scorecard - Earnings Growth Turns Positive
October 26, 2023
The Q3 revenue beats percentage of 63.2% is the lowest since the 61.7% for this group of companies in 2020 Q1.
Via
Talk Markets
Weight Loss Drugs Wegovy, Ozempic Gain Traction With Millennials, High Earners: New Survey Results
October 26, 2023
A new survey reveals the consumer segments showing the greatest interest in weight loss medications such as Ozempic, Mounjaro, and Wegovy.
Via
Benzinga
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
October 25, 2023
Employers could help bolster demand for weight-loss treatments.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 24, 2023
Via
Benzinga
2 Historically Cheap Dow Dividend Kings That Are Ripe for the Picking
October 24, 2023
These inexpensive Dow components have achieved royalty status among income stocks -- more than 60 consecutive years of dividend increases.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Novo Nordisk Unusual Options Activity
October 19, 2023
Via
Benzinga
3 Top Consumer Staples Stocks to Buy In Q4
October 23, 2023
Consumer staples stocks aren’t having a good year after delivering record gains in 2022. Here are three to buy for a rebound in 2024.
Via
InvestorPlace
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
October 23, 2023
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at...
Via
Talk Markets
Topics
Economy
Exposures
Economy
3 Stocks to Buy From the ‘Buy the Dip’ ETF
October 23, 2023
It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Healthcare Stocks to Invest in for a Big Shot of Gains
October 23, 2023
While healthcare stocks are down for the most part this year, there are a few names that offer the promise of big future profits.
Via
InvestorPlace
2 Stock-Split Stocks That Could Plunge Up to 89%, According to Select Wall Street Analysts
October 23, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are two high-flying stock-split stocks a pair of analysts believe will lose their...
Via
The Motley Fool
3 Unstoppable Stocks to Buy Sooner Rather Than Later
October 22, 2023
Now is the time to invest in these great stocks.
Via
The Motley Fool
Is Your Weight-loss Medication Genuine? Demand For Drugs From Novo Nordisk And Eli Lilly Leads To Surge In Counterfeits
October 21, 2023
As obesity rates climb worldwide, so does the demand
Via
Benzinga
Week In Review: China's Biopharmas Announce $2.5 Billion In Deals
October 21, 2023
KBP Biosciences sold global rights for its hypertension candidate to Novo Nordisk in an agreement worth up to $1.3 billion. Also, EpimAb Bio sold the rights to use its Fabs-In-Tandem Immunoglobulin...
Via
Talk Markets
This Stock-Split Stock Is Beating Both Apple and Microsoft in 2023 -- With No Artificial Intelligence (AI) Tailwind at All
October 21, 2023
This big pharma stock has been a big winner, thanks to two blockbuster drugs.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Mutual Funds to Invest in for Pro Management and Low Fees
October 20, 2023
People wanting to invest for the future without actively managing their own money should consider one of these top mutual funds.
Via
InvestorPlace
Two Stocks Set to Capitalize on the Surging Weight Loss Drug Trend
October 19, 2023
Several drugmakers have been thriving on the ongoing weight-loss trend, with Denmark's Novo Nordisk and Eli Lilly standing out in particular.
Via
Talk Markets
1 Market-Beating Stock to Buy Near Its 52-Week High
October 19, 2023
This stock has been firing on all cylinders -- and it isn't about to stop.
Via
The Motley Fool
4 Ways to Grow $100,000 Into $1 Million for Retirement
October 19, 2023
Investing for big-time growth doesn't have to be risky.
Via
The Motley Fool
1 Thing You'd Better Know Before You Invest in the Stocks Behind Ozempic and Mounjaro
October 19, 2023
Eli Lilly and Novo Nordisk are both battling demand issues for flagship treatments.
Via
The Motley Fool
Beware Of Fake Novo Nordisk's Ozempic - European, UK Regulators Warn About Fake Prefilled Pens
October 19, 2023
The European Medicines Agency warned about pre-filled pens falsely labeled as Novo Nordisk A/S's (NYSE: NVO) popular diabetes drug Ozempic at wholesalers in the
Via
Benzinga
7 Stocks to Buy and Hold for a Lifetime of Wealth
October 19, 2023
The best way to live a stress-free life and build wealth in the long term is to choose stocks to buy and hold. Here are 7 that fit the bill.
Via
InvestorPlace
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.